Supplemental Data For "Circulating Biomarker Results From a Phase 2 Study of Seralutinib in Pulmonary Arterial Hypertension"

20260 citationsDatasetgreen Open Access

Authors

Supplemental methods, figures and data for "Circulating Biomarker Results From a Phase 2 Study of Seralutinib in Pulmonary Arterial Hypertension"

Published in: Zenodo (CERN European Organization for Nuclear Research)